KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EBIT (2020 - 2025)

Historic EBIT for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $11.8 million.

  • Hims & Hers Health's EBIT fell 4722.89% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.0 million, marking a year-over-year increase of 16807.51%. This contributed to the annual value of $61.9 million for FY2024, which is 31017.55% up from last year.
  • As of Q3 2025, Hims & Hers Health's EBIT stood at $11.8 million, which was down 4722.89% from $26.7 million recorded in Q2 2025.
  • Hims & Hers Health's EBIT's 5-year high stood at $57.9 million during Q1 2025, with a 5-year trough of -$48.4 million in Q1 2021.
  • Its 5-year average for EBIT is -$2.9 million, with a median of -$9.2 million in 2023.
  • As far as peak fluctuations go, Hims & Hers Health's EBIT crashed by 167803.88% in 2021, and later soared by 474900.0% in 2024.
  • Quarter analysis of 5 years shows Hims & Hers Health's EBIT stood at -$21.6 million in 2021, then skyrocketed by 46.19% to -$11.6 million in 2022, then skyrocketed by 96.55% to -$400000.0 in 2023, then soared by 4749.0% to $18.6 million in 2024, then plummeted by 36.51% to $11.8 million in 2025.
  • Its EBIT stands at $11.8 million for Q3 2025, versus $26.7 million for Q2 2025 and $57.9 million for Q1 2025.